Harmony Brown, APRN
Acute Care · Santa Fe, NMNPI 1508333022
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 48 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by Exelixis Inc. at 59.7% of the total. Reporting peaked in 2023 at $1,508 and has fallen 75.3% since, to $373 in 2025.
Across 48 payments — averaging $48.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Exelixis Inc.$1K
- Johnson & Johnson$165
- Novartis$119
- AstraZeneca$92
- Takeda Pharmaceuticals U.S.A., Inc.$87
- Genmab U.S., Inc.$81
- plus $397 from 16 others
What the payments were for
- Food & beverage$2,336100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Exelixis Inc. | 3 | $1,394 |
| Johnson & Johnson | 7 | $165 |
| Novartis | 6 | $119 |
| AstraZeneca | 5 | $92 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $87 |
| Genmab U.S., Inc. | 3 | $81 |
| Seagen Inc. | 3 | $48 |
| Sobi, Inc | 2 | $46 |
| Bayer | 2 | $33 |
| Jazz Pharmaceuticals Inc. | 2 | $33 |
| Tersera Therapeutics LLC | 1 | $32 |
| Pharmacosmos Therapeutics Inc. | 1 | $23 |
| AbbVie | 1 | $22 |
| Puma Biotechnology, Inc. | 1 | $22 |
| Tempus AI, Inc | 1 | $20 |
| Pfizer | 1 | $20 |
| Daiichi Sankyo Inc. | 1 | $20 |
| Kyowa Kirin, Inc. | 1 | $19 |
| Beone Medicines USA, Inc. | 1 | $18 |
| Merck | 1 | $16 |
| GSK | 1 | $14 |
| Iovance Biotherapeutics, Inc. | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Cabometyx$1,348
How this compares
$2,336 in reported general payments places this provider in the 85th percentile of 132 acute care providers in New Mexico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 61 | $1,717 |
| Fentanyl | 20 | $1,634 |
| Olanzapine | 34 | $985 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 26 | $827 |
| Prochlorperazine Maleate | 21 | $488 |
| Morphine Sulfate | 16 | $364 |
| Duloxetine Hcl | 17 | $335 |
| Morphine Sulfate ErMorphine Sulfate | 18 | $334 |
| Gabapentin | 29 | $256 |
| Alprazolam | 16 | $253 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 15 | $200 |
| Dexamethasone | 12 | $167 |
| Clonazepam | 21 | $128 |
| Trazodone Hcl | 17 | $119 |
| Methylphenidate Hcl | 14 | $114 |
Paid to pharmacies, not to this prescriber.
Other acute care in Santa Fe
- Sara WhiteSanta Fe$11K
- Nataliya AfanasyevaSanta Fe$2K
- Sarah AragonSanta Fe$2K
- Kate FogartySanta Fe$592
- Lauren BowenSanta Fe$329
- Taryn DenezpiAlbuquerque$11K
- Catherine MahoneyAlbuquerque$10K
- Samantha MatteucciAlbuquerque$8K
- Bernadette HerreraLas Cruces$6K
- Isabel TorresAlbuquerque$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.